- All sections
- C - Chemistrymetallurgy
- C07C - Acyclic or carbocyclic compounds
- C07C 215/42 - Compounds containing amino and hydroxy groups bound to the same carbon skeleton having amino groups or hydroxy groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
Patent holdings for IPC class C07C 215/42
Total number of patents in this class: 71
10-year publication summary
6
|
6
|
6
|
8
|
6
|
1
|
2
|
4
|
0
|
0
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Bristol-myers Squibb Company | 4848 |
9 |
Techfields Biochem Co. Ltd | 17 |
6 |
Atrogi AB | 52 |
4 |
Sunovion Pharmaceuticals Inc. | 271 |
4 |
Advancion Corporation | 110 |
4 |
Grünenthal GmbH | 583 |
3 |
Taro Pharmaceuticals Inc. | 37 |
3 |
Bayer Pharma AG | 1058 |
2 |
Aquinox Pharmaceuticals (Canada) Inc. | 10 |
2 |
OCERA Therapeutics, Inc. | 40 |
2 |
Shandong Luye Pharmaceutical Co., Ltd. | 63 |
2 |
Recurium IP Holdings, LLC | 131 |
2 |
UNM Rainforest Innovations | 404 |
2 |
Neusignal Therapeutics, Inc. | 4 |
2 |
F. Hoffmann-La Roche AG | 7889 |
1 |
BASF SE | 20616 |
1 |
Janssen Pharmaceutica N.V. | 3436 |
1 |
Toshiba Corporation | 12246 |
1 |
Bayer AG | 3254 |
1 |
Dow Global Technologies LLC | 10247 |
1 |
Other owners | 18 |